Southern Blotting Market Size – Industry Structure Evaluation, Demand Drivers Analysis, Regional Growth Analysis and Identification, Competitive Positioning Review & Global Market Size Forecast to 2032
Overview
Global Southern Blotting Market was valued at USD 2.95 Bn in 2025 and is expected to reach USD 4.24 Bn by 2032, growing at a CAGR of 5.3% during the forecast period.
Global Southern Blotting Market Introduction
Southern blotting is one of the central techniques in molecular biology. Southern blotting results in transfer of DNA molecules, usually restriction fragments, from an electrophoresis gel to a nitrocellulose or nylon sheet (referred to as a ‘membrane’), in such a way that the DNA banding pattern present in the gel is reproduced on the membrane.
To Know About The Research Methodology :- Request Free Sample Report
Global Southern Blotting Market Dynamics
Growing incidence of many rare genetic disease worldwide is expected to drive growth of the global Southern blotting market during the forecast period. As per the estimates, there are over seven thousand rare genetic diseases prevalent globally with over 11% of U.S. population living with these diseases. Over 80% of these diseases are genetic in nature. As a result, pharmaceutical companies are spending heavily on R&D to develop effective drugs. Increased R&D spending coupled with increasing diagnostic cases is expected to create substantial opportunity for players engaged in southern blotting industry.
Moreover, growing use of Southern blotting in forensic science is expected to fuel the global Southern blotting market over the forecast period.
Key players in the market are expected to create substantial opportunity over the forecast period. It will be challenging for market players in capitalizing emerging regions wherein lower government funding along with high product pricing is a major cause of concerns for the players.
With rising incidence of diseases, rapid technological advancements in medical field, and increased spending in research and development, the global southern blotting market is expected to have a robust growth during the forecast period.
| Exact Date | Company | Development | Impact |
| 01 July 2025 | LICORbio | LICORbio finalized the strategic acquisition of SERVA Electrophoresis to expand its global portfolio of electrophoresis and blotting consumables. | This integration enhances the company's supply chain for high-purity reagents and membranes essential for DNA hybridization and Southern blotting workflows. |
| 30 October 2025 | LICORbio | The company officially launched SERVA Electrophoresis products across North America to provide standardized gel electrophoresis solutions for genomic research. | The rollout increases the availability of specialized blotting papers and buffers, driving higher workflow efficiency in molecular biology laboratories. |
| 12 January 2026 | Thermo Fisher Scientific | Thermo Fisher announced a strategic collaboration with NVIDIA to integrate AI-driven analytics into its scientific instrumentation and laboratory software. | This partnership aims to automate data interpretation for complex blotting and imaging results, accelerating high-throughput genomic validation and research. |
| 09 February 2026 | LICORbio | LICORbio debuted the Atlas™ Imager at the SLAS 2026 conference, featuring advanced digital detection capabilities for various blotting techniques. | The system provides increased sensitivity for DNA and protein detection, offering a modern digital alternative to traditional film-based Southern blotting methods. |
| 12 February 2026 | Bio-Rad Laboratories, Inc. | Bio-Rad reported that despite constraints in academic research funding, its Life Science segment maintained robust demand for core laboratory consumables. | Steady sales in electrophoresis and reagents highlight the continued reliance on Southern blotting as a gold standard for genetic mutation and pathogen detection. |
| 04 March 2026 | Thermo Fisher Scientific | Thermo Fisher expanded its immunodiagnostics operations with the opening of a new Distribution and Labeling Center in Uppsala, Sweden. | The new facility strengthens the logistical network for distributing diagnostic kits and membranes, supporting regional market growth for DNA analysis in Europe. |
Global Southern Blotting Market Segment Analysis
In 2025, the Product segment of the Southern blotting market is dominated by Consumables and Reagents, which account for the highest demand. Consumables such as membranes, blotting papers, and buffers are repeatedly required in laboratory workflows, leading to consistent purchasing by research and diagnostic laboratories. Reagents, including hybridization buffers and detection chemicals, are also essential for performing Southern blot experiments and contribute significantly to market revenue. Kits are gaining popularity as they provide standardized protocols and simplified workflows, especially for laboratories seeking efficiency and reproducibility. Instruments, while essential for blotting and detection processes, represent a comparatively smaller share because they are long-term investments and are purchased less frequently than consumables.
Based on Application, Scientific Research represents the largest and most prominent segment in 2025. Southern blotting remains a reliable method for DNA analysis, gene mapping, and validation of genetic modifications in molecular biology research. Medical Diagnosis is another important application area, particularly in detecting genetic disorders and confirming specific DNA sequences in clinical studies. Genetic Fingerprinting and Sex Determination are widely used in forensic science and biological studies, supporting identification and genetic profiling. Agricultural Applications are also expanding as researchers use Southern blotting to study genetically modified crops, plant breeding, and gene integration, although demand in this segment is comparatively moderate.
| Southern Blotting Market | |||
|---|---|---|---|
| Report Coverage | Details | ||
| Base Year: | 2025 | Forecast Period: | 2026-2032 |
| Historical Data: | 2020 to 2025 | Market Size in 2025: | 2.95 USD Bn |
| Forecast Period 2026-2032 CAGR: | 5.3% | Market Size in 2032: | 4.24 USD Bn |
| Segments Covered: | by Product | Consumables Instruments Reagents Kits |
|
| by Application | Scientific Research Medical Diagnosis Agricultural Applications Genetic fingerprinting and sex determination |
||
| by End User | Pharmaceutical & Biotechnology Industry Academic Research Institute Forensic Labs Contract Research Organizations |
||
Global Southern Blotting Market Regional Insights
Based on Region, North America leads the global Southern blotting market in 2025, supported by strong investments in biotechnology research, well-established laboratory infrastructure, and high adoption of advanced molecular biology techniques. The presence of major biotechnology companies and leading academic institutions further drives regional demand. Europe holds a substantial share due to active genomic research programs and government support for life sciences innovation. Asia Pacific is witnessing the fastest growth, fueled by expanding biotechnology industries, increasing research funding, and rising academic collaborations in countries such as China, Japan, and India. Other regions, including Latin America and the Middle East & Africa, show gradual growth driven by improving healthcare infrastructure and expanding research capabilities.
Global Southern Blotting Market: By Region
North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)
Key Players /Competitor Profiles Covered in the Southern Blotting Market Report from a Strategic Perspective.
- Thermo Fisher Scientific
- Bio-Rad Laboratories
- Merck KGaA
- GE Healthcare
- PerkinElmer
- Danaher Corporation
- Agilent Technologies
- Promega Corporation
- Takara Bio
- Roche Diagnostics
- QIAGEN
- New England Biolabs
- Abcam
- Bio-Techne
- Lonza Group
- Cytiva
- GenScript Biotech
- Santa Cruz Biotechnology
- Enzo Life Sciences
- Rockland Immunochemicals
- MP Biomedicals
- Oxford Gene Technology
- LGC Biosearch Technologies
- Biotium
- Creative Diagnostics